Baseline metabolites could predict responders with hepatitis B virus-related liver fibrosis for entecavir or combined with FuzhengHuayu tablet

doi:10.4254/wjh.v15.i9.1043

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 9

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (1891)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-6) series, Tables (1-2) series.

Item

Count

PDF

WORD

HTML

687

Figures (1-6)

105

Tables (1-2)

145

Sum=1001

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

164

Download

413

Sum=577

Publishing Process of This Article

Item

Count

Browse

Download

171

Sum=258

Sep 27, 2023 (publication date) through Jun 10, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Hepatol. Sep 27, 2023; 15(9): 1043-1059
Published online Sep 27, 2023. doi: 10.4254/wjh.v15.i9.1043

Full Size Figure Download Figure

Figure 1 Orthogonal partial least squares discriminant analysis of all the metabolites. A: Score of entecavir responders (E-R) vs entecavir no-responders (E-N); B: Score of FuzhengHuayu tablet (FZHY) + entecavir responders (F-R) vs FZHY + entecavir no-responders (F-N); C: Score of patients vs volunteers; D: R²X and R²Y of E-R vs E-N; E: R²X and R²Y of F-R vs F-N; F: R²X and R²Y of patients vs volunteers.

Citation: Dai YK, Fan HN, Huang K, Sun X, Zhao ZM, Liu CH. Baseline metabolites could predict responders with hepatitis B virus-related liver fibrosis for entecavir or combined with FuzhengHuayu tablet. World J Hepatol 2023; 15(9): 1043-1059
URL: https://www.wjgnet.com/1948-5182/full/v15/i9/1043.htm
DOI: https://dx.doi.org/10.4254/wjh.v15.i9.1043